Published in Med Phys on May 01, 2010
Spatially resolved regression analysis of pre-treatment FDG, FLT and Cu-ATSM PET from post-treatment FDG PET: an exploratory study. Radiother Oncol (2012) 0.81
Segmentation of organs-at-risks in head and neck CT images using convolutional neural networks. Med Phys (2017) 0.75
Clinical outcomes of adaptive radiotherapy in head and neck cancers. Br J Radiol (2016) 0.75
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys (2004) 3.21
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol (2002) 3.11
Overview of image-guided radiation therapy. Med Dosim (2006) 3.07
Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2005) 2.35
Cone-beam-CT guided radiation therapy: technical implementation. Radiother Oncol (2005) 2.23
Evaluation of on-board kV cone beam CT (CBCT)-based dose calculation. Phys Med Biol (2007) 2.02
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol (2006) 1.97
Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys (2009) 1.96
Dosimetric feasibility of cone-beam CT-based treatment planning compared to CT-based treatment planning. Int J Radiat Oncol Biol Phys (2006) 1.72
An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys (2000) 1.70
Cone-beam-CT guided radiation therapy: A model for on-line application. Radiother Oncol (2005) 1.66
Setup uncertainties of anatomical sub-regions in head-and-neck cancer patients after offline CBCT guidance. Int J Radiat Oncol Biol Phys (2009) 1.57
Scatter correction for cone-beam CT in radiation therapy. Med Phys (2009) 1.55
Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? Int J Radiat Oncol Biol Phys (2007) 1.41
Formulating adaptive radiation therapy (ART) treatment planning into a closed-loop control framework. Phys Med Biol (2007) 1.37
The use of megavoltage CT (MVCT) images for dose recomputations. Phys Med Biol (2005) 1.36
Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. J Clin Oncol (1999) 1.33
Retrospective IMRT dose reconstruction based on cone-beam CT and MLC log-file. Int J Radiat Oncol Biol Phys (2008) 1.29
Mapping of the prostate in endorectal coil-based MRI/MRSI and CT: a deformable registration and validation study. Med Phys (2004) 1.21
How does CT image noise affect 3D deformable image registration for image-guided radiotherapy planning? Med Phys (2008) 1.17
Feature-based rectal contour propagation from planning CT to cone beam CT. Med Phys (2008) 1.15
Multiscale deformable registration of noisy medical images. Math Biosci Eng (2008) 1.08
Computational challenges for image-guided radiation therapy: framework and current research. Semin Radiat Oncol (2007) 1.05
An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. Int J Radiat Oncol Biol Phys (2005) 1.05
Tumor-volume simulation during radiotherapy for head-and-neck cancer using a four-level cell population model. Int J Radiat Oncol Biol Phys (2009) 0.95
Verification of in-treatment tumor position using kilovoltage cone-beam computed tomography: a preliminary study. Int J Radiat Oncol Biol Phys (2007) 0.92
Detection of intrafractional tumour position error in radiotherapy utilizing cone beam computed tomography. Radiother Oncol (2008) 0.90
Lysyl oxidase is essential for hypoxia-induced metastasis. Nature (2006) 8.28
Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med (2008) 6.82
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell (2009) 6.66
SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet (2005) 5.23
Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol (2010) 4.39
Non-small cell lung cancer. J Natl Compr Canc Netw (2010) 3.93
Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell (2009) 3.68
XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res (2004) 3.24
Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys (2003) 3.14
Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol (2007) 2.80
Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging (2012) 2.34
Sample classification from protein mass spectrometry, by 'peak probability contrasts'. Bioinformatics (2004) 2.28
Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol Cell (2011) 2.27
The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys (2009) 2.26
Bridging the gap between IMRT and VMAT: dense angularly sampled and sparse intensity modulated radiation therapy. Med Phys (2011) 2.18
Objective assessment of deformable image registration in radiotherapy: a multi-institution study. Med Phys (2008) 2.15
Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2005) 2.10
Four-dimensional cone-beam computed tomography using an on-board imager. Med Phys (2006) 2.08
Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. Transl Oncol (2010) 2.03
Evaluation of on-board kV cone beam CT (CBCT)-based dose calculation. Phys Med Biol (2007) 2.02
MiR-210--micromanager of the hypoxia pathway. Trends Mol Med (2010) 1.90
GPU computing in medical physics: a review. Med Phys (2011) 1.85
Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons. J Neurosci (2006) 1.80
Iterative image reconstruction for CBCT using edge-preserving prior. Med Phys (2009) 1.80
X-ray luminescence computed tomography via selective excitation: a feasibility study. IEEE Trans Med Imaging (2010) 1.76
Expression of the proto-oncogene Fos after exposure to radiofrequency radiation relevant to wireless communications. Radiat Res (2005) 1.73
Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.73
Model-based image reconstruction for four-dimensional PET. Med Phys (2006) 1.71
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2009) 1.71
Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys (2004) 1.70
Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys (2007) 1.69
Enhanced 4D cone-beam CT with inter-phase motion model. Med Phys (2007) 1.69
Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 1.68
Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2012) 1.68
Compressed sensing based cone-beam computed tomography reconstruction with a first-order method. Med Phys (2010) 1.68
Noise suppression in scatter correction for cone-beam CT. Med Phys (2009) 1.66
Tomographic molecular imaging of x-ray-excitable nanoparticles. Opt Lett (2010) 1.65
MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol (2011) 1.61
Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2011) 1.57
Scatter correction for cone-beam CT in radiation therapy. Med Phys (2009) 1.55
Comparison of treatment results between adult and juvenile nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2009) 1.54
Effects of radiation on the epidermal growth factor receptor pathway in the heart. Int J Radiat Biol (2013) 1.49
Image interpolation in 4D CT using a BSpline deformable registration model. Int J Radiat Oncol Biol Phys (2006) 1.49
Optimizing 4D cone-beam CT acquisition protocol for external beam radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.46
Dose reduction for kilovotage cone-beam computed tomography in radiation therapy. Phys Med Biol (2008) 1.46
OCT assessment of allograft vasculopathy in heart transplant recipients. JACC Cardiovasc Imaging (2012) 1.43
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003. J Clin Oncol (2008) 1.38
Formulating adaptive radiation therapy (ART) treatment planning into a closed-loop control framework. Phys Med Biol (2007) 1.37
18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J Nucl Med (2006) 1.37
PET of EGFR antibody distribution in head and neck squamous cell carcinoma models. J Nucl Med (2009) 1.36
Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thorac Surg (2003) 1.34
Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol (2010) 1.33
Intraoperative imaging of tumors using Cerenkov luminescence endoscopy: a feasibility experimental study. J Nucl Med (2012) 1.30
Using total-variation regularization for intensity modulated radiation therapy inverse planning with field-specific numbers of segments. Phys Med Biol (2008) 1.30
Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma. Clin Cancer Res (2010) 1.29
Four-dimensional inverse treatment planning with inclusion of implanted fiducials in IMRT segmented fields. Med Phys (2009) 1.29
Retrospective IMRT dose reconstruction based on cone-beam CT and MLC log-file. Int J Radiat Oncol Biol Phys (2008) 1.29
Segment-based dose optimization using a genetic algorithm. Phys Med Biol (2003) 1.26
Synthesis and radioluminescence of PEGylated Eu(3+) -doped nanophosphors as bioimaging probes. Adv Mater (2011) 1.26
Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. J Pain Symptom Manage (2009) 1.25
Investigation of X-ray fluorescence computed tomography (XFCT) and K-edge imaging. IEEE Trans Med Imaging (2012) 1.24
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys (2009) 1.24
Hypoxia in models of lung cancer: implications for targeted therapeutics. Clin Cancer Res (2010) 1.19
Validation that metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2012) 1.18
First demonstration of multiplexed X-ray fluorescence computed tomography (XFCT) imaging. IEEE Trans Med Imaging (2012) 1.16
Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli. Microb Cell Fact (2011) 1.16
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). Int J Radiat Oncol Biol Phys (2010) 1.16
Search for IMRT inverse plans with piecewise constant fluence maps using compressed sensing techniques. Med Phys (2009) 1.16
Multiscale registration of planning CT and daily cone beam CT images for adaptive radiation therapy. Med Phys (2009) 1.15
Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis. Cancer Res (2011) 1.15
In vivo MRSI of hyperpolarized [1-(13)C]pyruvate metabolism in rat hepatocellular carcinoma. NMR Biomed (2010) 1.15
Feature-based rectal contour propagation from planning CT to cone beam CT. Med Phys (2008) 1.15
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2010) 1.15
Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck (2007) 1.14
The effectiveness of breath-holding to stabilize lung and pancreas tumors during radiosurgery. Int J Radiat Oncol Biol Phys (2002) 1.14
Patterns of care in palliative radiotherapy: a population-based study. J Oncol Pract (2013) 1.13
High-resolution radioluminescence microscopy of 18F-FDG uptake by reconstructing the β-ionization track. J Nucl Med (2013) 1.12
Image registration with auto-mapped control volumes. Med Phys (2006) 1.11
Plasma osteopontin is an independent prognostic marker for head and neck cancers. J Clin Oncol (2006) 1.11
Hybrid multiscale landmark and deformable image registration. Math Biosci Eng (2007) 1.10
Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer. Oncogene (2005) 1.10
A fiducial detection algorithm for real-time image guided IMRT based on simultaneous MV and kV imaging. Med Phys (2008) 1.10
Pancreatic tumor motion on a single planning 4D-CT does not correlate with intrafraction tumor motion during treatment. Am J Clin Oncol (2009) 1.09
Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2007) 1.08
Multiscale deformable registration of noisy medical images. Math Biosci Eng (2008) 1.08
Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. J Thorac Oncol (2012) 1.08
Radioluminescence microscopy: measuring the heterogeneous uptake of radiotracers in single living cells. PLoS One (2012) 1.06
The tumor microenvironment in non-small-cell lung cancer. Semin Radiat Oncol (2010) 1.06
The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways. PLoS One (2010) 1.06
An adaptive planning strategy for station parameter optimized radiation therapy (SPORT): Segmentally boosted VMAT. Med Phys (2013) 1.05
Reducing respiratory motion artifacts in positron emission tomography through retrospective stacking. Med Phys (2006) 1.04
Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer (2007) 1.03
Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging (2012) 1.03
Dead or alive? Autofluorescence distinguishes heat-fixed from viable cells. Int J Hyperthermia (2009) 1.03
Aperture modulated arc therapy. Phys Med Biol (2003) 1.03
Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology. Med Phys (2005) 1.03